Area of research
Genetics · Biotechnology
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Research and Treatments, CAR-T cell therapy research, and Virus-based gene therapy research.
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
Intramuscular (IM) INO-5401 + INO-9012 with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma.
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)
Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients
LTBK-01. INO-5401 AND INO-9012 DELIVERED INTRAMUSCULARLY (IM) WITH ELECTROPORATION (EP) IN COMBINATION WITH CEMIPLIMAB (REGN2810) IN NEWLY DIAGNOSED GLIOBLASTOMA
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma